BlackRock, acting on behalf of clients and funds, has declared to the AMF that on March 6 it crossed below the threshold of 5% of Arkema's share capital, holding 4.92% of the capital and 3.97% of the voting rights in the chemicals group.

The American asset management giant explained that this threshold crossing was the result of an off-market sale of Arkema shares and a reduction in the number of shares held as collateral.

Copyright (c) 2024 CercleFinance.com. All rights reserved.